Editas Medicine (EDIT) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.38. This compares to a loss of $0.75 per share a year ago. These figures ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results